Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 7/12/2020
E.g., 7/12/2020
Title Status FDA Centersort ascending Date Posted
Mini-Sentinel: Utilization of the DaVinci Device and Other Robotic-Assisted Devices Complete CDRH 01/22/2020
Trends in Fibroid Surgery and Use of Power Morcellation Complete CDRH 12/14/2017
Use of Stents Complete CDRH 01/23/2018
Nursing Home HCPCS Codes Complete CDER 12/29/2013
Suicide Diagnoses Complete CDER 12/15/2017
Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System Complete CDER 12/06/2019
Analgesics Use Complete CDER 08/02/2012
Parenteral Iron and Anaphylactoid Reactions Complete CDER 07/22/2016
Duration of Use for Teriparatide Complete CDER 11/29/2018
Occurrence of Selected Generic Drugs 12 In progress CDER 09/22/2014
Counts, Prevalence, and Incidence of Intravenous (IV) Iron Products In progress CDER 03/02/2018
Prevalent and Incident Use of Quinine Sulfate Complete CDER 01/08/2014
Prevalent and Incident Use of Romiplostim In progress CDER 12/18/2017
Attention Deficit Hyperactivity Disorder (ADHD) Medications and Heart Failure Complete CDER 10/25/2016
Mini-Sentinel: Summary of Antidiabetic Agent Use During Pregnancy Complete CDER 01/02/2020
Dalfampridine Use Complete CDER 08/02/2012
Dabigatran and Warfarin Use Among Members with Atrial Fibrillation and Other Pre-Existing Conditions Complete CDER 07/21/2016
Pulmonary Arterial Hypertension and Interstitial Lung Disease Events Among Interleukin Inhibitor Users Complete CDER 12/03/2018
Antiepileptic Drugs (AEDs) and Kidney Stones 2 Complete CDER 09/23/2014
Combined Oral Contraceptives Containing Ethinyl Estradiol and Levonorgestrel and Venous Thromboembolism Complete CDER 03/04/2018
Quinine Sulfate, Diltiazem and Selected Thrombotic Events Complete CDER 01/08/2014
Gadolinium-Based Contrast Agents (GBCAs) Use in Pregnancy Complete CDER 04/04/2019
Hydroxyurea Use in Patients with Sickle Cell Anemia Complete CDER 01/07/2020
Propylthiouracil and Methimazole Use Complete CDER 08/02/2012
MRI and GBCA Procedures Complete CDER 07/21/2016
Use of Multiple Sclerosis Drugs Among Pregnant Women Complete CDER 12/06/2018
Infectious Disease Diagnoses Complete CDER 09/23/2014
Exposure to Intravenous (IV) Iron Procedures and Anaphylaxis and Epinephrine Events Complete CDER 03/02/2018
Antiepileptic Drugs (AEDs) and Kidney Stones Complete CDER 01/07/2014
Prevalent and Incident Use of Testosterone Products In progress CDER 12/21/2017
Dabigatran, Rivaroxaban, and Warfarin Use Complete CDER 05/03/2013
Influenza Antiviral Drug Use 2010-2015 Complete CDER 05/02/2017
Use of Metoclopramide among Patients with Diabetic Gastroparesis and Type 2 Diabetes Complete CDER 01/13/2020
Occurrence of Selected Generic Drugs 2 Complete CDER 08/02/2012
Acute Myocardial Infarction and Heart Failure following Saxagliptin or Sitagliptin Use: A Propensity Score Matched Analysis In progress CDER 04/01/2019
Dialysis HCPCS Procedure Codes Complete CDER 10/14/2014
Venous Thromboembolism following Continuous or Extended Cycle Contraceptive Use: A Propensity Score Matched Analysis Complete CDER 03/04/2018
Dialysis ICD9 Diagnosis Codes Complete CDER 10/13/2014
Drug Utilization Over Time for Three Drug Classes Complete CDER 03/05/2018
Anti-Seizure Medication Use Complete CDER 01/08/2014
Top 100 Procedures and Diagnoses 30 Days Surrounding Incident Warfarin Use Complete CDER 12/21/2017
Dabigatran, Warfarin and GI Bleed, Intracerebral Hemorrhage Complete CDER 05/03/2013
Prevalent Dispensings of Ticagrelor (Brilinta) and Vortioxetine Hydrobromide (Brintellix) Complete CDER 04/23/2017
Occurrence of Selected HCPCS Codes 2 Complete CDER 08/02/2012
Hysterectomy Procedures Among Females Complete CDER 07/21/2016
Stroke, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Apixaban or Warfarin Use in Patients with Non-Valvular Atrial Fibrillation: A Propensity Score Matched Analysis In progress CDER 02/15/2019
Anti-Diabetes Drugs and Acute Myocardial Infarction, Hospitalized Heart Failure Complete CDER 01/26/2016
Drugs that Act on the Renin-Angiotensin-Aldosterone System (Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Aliskiren) and Angioedema Complete CDER 10/19/2012
Dialysis ICD9 Procedure Codes Complete CDER 10/13/2014
Selected Medications and Death, with Linkage of Mini-Sentinel Distributed Database with NDI+ Discontinued CDER 03/06/2018
Occurrence of Selected Generic Drugs 11 Complete CDER 01/08/2014
Anti-Tumor Necrosis Factor (TNF) Utilization Among Pregnant Women Complete CDER 12/20/2017
Warfarin and GI Bleed, Intracerebral Hemorrhage Complete CDER 05/03/2013
Multiple Births and Preterm Deliveries Complete CDER 05/10/2017
Prenatal Tests in Women with Potential Stillbirths Complete CDER 01/24/2020
Occurrence of Selected Generic Drugs 1 Complete CDER 08/30/2012
Most Frequent Generic Dispensings Among Members Aged 65+ Complete CDER 07/21/2016
Optimal Initial Length of Opioid Prescription Complete CDER 02/01/2019
Smoking Cessation Drugs and Cardiovascular Outcomes Complete CDER 01/15/2012
Activa Tremor Control Diagnoses Complete CDER 10/15/2014
Incident Use of Rivaroxaban Complete CDER 03/07/2018
Multiple Sclerosis Medication Use Complete CDER 01/08/2014
Vascular Endothelial Growth Factor (VEGF) Inhibitor Prevalent and Incident Use Complete CDER 05/09/2013
Drug Use Following Genetic Testing Among Patients with Cancer Complete CDER 05/10/2017
Duration of Follow-up for Individuals with Chronic Conditions Complete CDER 01/23/2020
Occurrence of Selected HCPCS Codes 1 Complete CDER 08/30/2012
Incident Testosterone Indication Diagnoses and Testosterone Use Complete CDER 07/06/2016
Non-Melanoma Skin Cancer following Hydrochlorothiazide Use: A Propensity Score Matched Analysis Complete CDER 03/06/2020
Angiotensin II Receptor Blockers and Celiac Disease Complete CDER 01/16/2012
Activa Tremor Control Procedures Complete CDER 10/16/2014
Prevalent and Incident Use of Generic Name Kinase Inhibitors In progress CDER 03/08/2018
Multiple Sclerosis Medication Injections Complete CDER 01/08/2014
Use of Ospemifene, Boceprevir, and Telaprevir In progress CDER 12/29/2017
Parkinson’s Disease Medication Use Complete CDER 06/07/2013
Time Until Guillain-Barré Syndrome or Bell's Palsy Diagnosis following Initiation of Checkpoint Inhibitor Treatment Complete CDER 01/24/2020